Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NEOG · against 588 other Healthcare companies listed in US-listed
Ranked #234 of 589 · scores higher than 60% of peers
Bars: peers in each 10-point band of the valuation score75 peers with a valuation score of 30–39, including NEOG · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | NEOG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -2.1% | -4.3% | 56% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 3.4% | -0.8% | 63% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | 1.2% | -2.3% | 63% | 20% | |
| Book yieldHigher is better · 587 reported | 79.1% | 25.9% | 87% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 232 | 1.2B USD | 40 | 42 | |
| 232 | 7.3B USD | 40 | 74 | |
| 234 | 1.5B USD | 39 | 63 | |
| 234 | 9.4B USD | 39 | 70 | |
| 234 | 2.6B USD | 39 | 32 | |
| 234 | 354M USD | 39 | 41 | |
| 234 | 1.6B USD | 39 | 43 | |
| 239 | 4.0B USD | 38 | 56 | |
| 239 | 1.6B USD | 38 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score